Hepatitis A
📧 Sign up to get email alerts when something new happens for Hepatitis A.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-03-02Clinical Trial Update: Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel [Phase 4]
A Phase 4 clinical trial evaluating the immunogenicity and persistence of Havrix in healthy adults vaccinated in infancy under Israel's univ…
-
CLINICAL_TRIALS withdrawal · 2015-11-18Clinical Trial Update: Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) [Phase 4]
This Phase 4 study evaluating long-term hepatitis A and B antibody persistence in healthy adults previously primed with Twinrix has been wit…
-
CLINICAL_TRIALS withdrawal · 2015-11-18Clinical Trial Update: Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix® [Phase 4]
A Phase 4 clinical trial assessing long-term persistence of hepatitis A antibodies after Havrix vaccination 21-25 years earlier has been wit…